New drug combinations may benefit patients with pancreatic cancer
Two drug combinations that simultaneously block two major signaling pathways downstream of the protein KRAS, which is aberrantly active in most pancreatic cancers, may provide a new treatment option for patients with this ...
Oct 21, 2013